FIRST TR NYSE ARCA BIOTECHNOLGY ETF UNITFIRST TR NYSE ARCA BIOTECHNOLGY ETF UNITFIRST TR NYSE ARCA BIOTECHNOLGY ETF UNIT

FIRST TR NYSE ARCA BIOTECHNOLGY ETF UNIT

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪1.56 M‬CAD
Fund flows (1Y)
‪−784.30 K‬CAD
Dividend yield (indicated)
Discount/Premium to NAV
0.1%

About FIRST TR NYSE ARCA BIOTECHNOLGY ETF UNIT


Issuer
AJM Ventures LLC
Brand
First Trust
Expense ratio
0.73%
Home page
Inception date
Feb 17, 2021
Index tracked
NYSE Arca Biotechnology (TR)
Management style
Passive
The fund provides exposure to biotech companies involved in the use of biological processes to develop products or provide services. The underlying index contains 30 names, an increase from 20 in October 2014. Without a specific sector classification scheme, the funds broad exposure could include access to pharmaceuticals and medical technology in addition to traditional biotech. Still, FBTs equal weighting of about 30 stocks produces a relatively concentrated basket. The index is reconstituted and rebalanced quarterly.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Vanilla
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of December 9, 2024
Exposure type
Bonds, Cash & Other
ETF
Bonds, Cash & Other100.00%
ETF99.97%
Cash0.03%
Stock breakdown by region
100%
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows